These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 8021775)

  • 21. Outcome of infants 23-26 weeks' gestation pre and post surfactant.
    Jacobs SE; O'Brien K; Inwood S; Kelly EN; Whyte HE
    Acta Paediatr; 2000 Aug; 89(8):959-65. PubMed ID: 10976839
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Surfactant replacement therapy: a second look.
    Lynam LE
    Neonatal Netw; 1990 Oct; 9(3):79-81. PubMed ID: 2215450
    [No Abstract]   [Full Text] [Related]  

  • 23. Randomized, placebo-controlled trial of human surfactant given at birth versus rescue administration in very low birth weight infants with lung immaturity.
    Merritt TA; Hallman M; Berry C; Pohjavuori M; Edwards DK; Jaaskelainen J; Grafe MR; Vaucher Y; Wozniak P; Heldt G
    J Pediatr; 1991 Apr; 118(4 Pt 1):581-94. PubMed ID: 2007937
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A multicenter, randomized trial comparing synthetic surfactant with modified bovine surfactant extract in the treatment of neonatal respiratory distress syndrome. Vermont-Oxford Neonatal Network.
    Pediatrics; 1996 Jan; 97(1):1-6. PubMed ID: 8545199
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pumactant and poractant alfa surfactant treatment.
    Gillespie L; Madar J
    Lancet; 2000 Jul; 356(9224):167-8. PubMed ID: 10963277
    [No Abstract]   [Full Text] [Related]  

  • 26. The 5 W's of surfactant for respiratory distress syndrome of the premature infant.
    Parmigiani S
    J Matern Fetal Neonatal Med; 2004 Nov; 16 Suppl 2():25-7. PubMed ID: 15590430
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic value of the immediate response to surfactant.
    Kuint J; Reichman B; Neumann L; Shinwell ES
    Arch Dis Child Fetal Neonatal Ed; 1994 Nov; 71(3):F170-3. PubMed ID: 7820711
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Surfactant therapy in respiratory distress syndrome; a review].
    de Winter JP; van Sonderen L; Egberts J; van Bel F
    Ned Tijdschr Geneeskd; 1992 Oct; 136(41):2010-3. PubMed ID: 1407190
    [No Abstract]   [Full Text] [Related]  

  • 29. A controlled trial of human surfactant replacement therapy for severe respiratory distress syndrome in very low birth weight infants.
    Lang MJ; Hall RT; Reddy NS; Kurth CG; Merritt TA
    J Pediatr; 1990 Feb; 116(2):295-300. PubMed ID: 2405141
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Minimally Invasive Surfactant Therapy vs Sham Treatment and Death or Bronchopulmonary Dysplasia in Preterm Infants With Respiratory Distress Syndrome.
    Razak A
    JAMA; 2022 Apr; 327(16):1613. PubMed ID: 35471524
    [No Abstract]   [Full Text] [Related]  

  • 31. Minimally Invasive Surfactant Therapy vs Sham Treatment and Death or Bronchopulmonary Dysplasia in Preterm Infants With Respiratory Distress Syndrome.
    Zhou P; Han T
    JAMA; 2022 Apr; 327(16):1613-1614. PubMed ID: 35471523
    [No Abstract]   [Full Text] [Related]  

  • 32. In response to mortality in preterm infants with respiratory distress syndrome treated with poractant alfa, calfactant or beractant: a retrospective study.
    Egan EA
    J Perinatol; 2013 Feb; 33(2):165-6. PubMed ID: 23361501
    [No Abstract]   [Full Text] [Related]  

  • 33. [Prevention and treatment of respiratory distress syndrome in premature infants using intratracheally administered surfactants].
    de Winter JP; Egberts J; de Kleine MJ; van Bel F; Wijnands JB; Guit GL
    Ned Tijdschr Geneeskd; 1992 Oct; 136(41):2018-24. PubMed ID: 1407193
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Surfactant-replacement therapy for respiratory distress syndrome in the preterm and term neonate: congratulations and corrections.
    Moya F; Sinha S; D'Agostino RB
    Pediatrics; 2008 Jun; 121(6):1290-1; author reply 1291-2. PubMed ID: 18519504
    [No Abstract]   [Full Text] [Related]  

  • 35. [Surfactant replacement therapy for respiratory distress syndrome: a pilot study].
    Shinwell ES; Zmora E; Leven D; Berger I; Karplus M
    Harefuah; 1992 Jul; 123(1-2):1-4, 72. PubMed ID: 1505835
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Minimally Invasive Surfactant Therapy vs Sham Treatment and Death or Bronchopulmonary Dysplasia in Preterm Infants With Respiratory Distress Syndrome-Reply.
    Dargaville PA; Carlin JB; Davis PG;
    JAMA; 2022 Apr; 327(16):1614-1615. PubMed ID: 35471518
    [No Abstract]   [Full Text] [Related]  

  • 37. [A multicenter study on the surfactant treatment in late-preterm or term infants with respiratory distress syndrome].
    Collaborative Study Group for Late-preterm/Term Infants with Respiratory Distress
    Zhonghua Er Ke Za Zhi; 2014 Oct; 52(10):724-8. PubMed ID: 25537535
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Repeat surfactant therapy for postsurfactant slump.
    Katz LA; Klein JM
    J Perinatol; 2006 Jul; 26(7):414-22. PubMed ID: 16724122
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Surfactant treatment of premature infants with respiratory distress syndrome].
    Saugstad OD; Gloppestad K
    Tidsskr Nor Laegeforen; 1990 Nov; 110(29):3737-41. PubMed ID: 2274941
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Surfactant use in premature neonates <37 weeks gestation: Experience and outcome at a tertiary care hospital.
    Khan EA; Hashmey I
    J Pak Med Assoc; 2015 May; 65(5):486-90. PubMed ID: 26028381
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.